Skip to main content
Clinical Trials/CTRI/2020/12/030151
CTRI/2020/12/030151Not yet recruitingPhase 4

Evaluation of the effects of different doses of dexmedetomidine added as adjuvant to bupivacaine in subarachnoid blocks for elective caesarean section - A prospective, randomized, triple-blind controlled study - DBCS

Dr Ramana Reddy MV0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Eighty adult patients of age between 20 and 40 yrs, height between 145 and 170 cm and of American Society of Anaesthesiologists (ASA) grade I and II, attending our medical college hospital with uncomplicated singleton pregnancies of more than 36 weeks of gestation for elective lower segment caesarean surgeries

Exclusion Criteria

  • patients with known allergy to study drugs, patient refusal of local anaesthetic block, patients suffering from neurological disorders, psychiatric disorders, mental retardation, uncontrolled hypertension and diabetes mellitus, coagulation or bleeding abnormalities, severe spinal deformity, history of preeclampsia, twin gestations, infection at spinal injection site or any contraindication to spinal anaesthesia and cases posted for emergency caesarean section

Investigators

Sponsor
Dr Ramana Reddy MV

Similar Trials